Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.

<h4>Background</h4>Fabry disease (FD) is caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (GLA) resulting in the accumulation of globotriaosylsphingosine (Gb3) in a variety of tissues. While GLA deficiency was always considered as the fulcrum of the disease, recent at...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mehdi Namdar, Catherine Gebhard, Rafael Studiger, Yi Shi, Pavani Mocharla, Christian Schmied, Pedro Brugada, Thomas F Lüscher, Giovanni G Camici
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/22cdef7e000f48a58838623c6de322ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:22cdef7e000f48a58838623c6de322ef
record_format dspace
spelling oai:doaj.org-article:22cdef7e000f48a58838623c6de322ef2021-11-18T07:20:08ZGlobotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.1932-620310.1371/journal.pone.0036373https://doaj.org/article/22cdef7e000f48a58838623c6de322ef2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22558451/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Fabry disease (FD) is caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (GLA) resulting in the accumulation of globotriaosylsphingosine (Gb3) in a variety of tissues. While GLA deficiency was always considered as the fulcrum of the disease, recent attention shifted towards studying the mechanisms through which Gb3 accumulation in vascular cells leads to endothelial dysfunction and eventually multiorgan failure. In addition to the well-described macrovascular disease, FD is also characterized by abnormalities of microvascular function, which have been demonstrated by measurements of myocardial blood flow and coronary flow reserve. To date, the relative importance of Gb3 accumulation versus GLA deficiency in causing endothelial dysfunction is not fully understood; furthermore, its differential effects on cardiac micro- and macrovascular endothelial cells are not known.<h4>Methods and results</h4>In order to assess the effects of Gb3 accumulation versus GLA deficiency, human macro- and microvascular cardiac endothelial cells (ECs) were incubated with Gb3 or silenced by siRNA to GLA. Gb3 loading caused deregulation of several key endothelial pathways such as eNOS, iNOS, COX-1 and COX-2, while GLA silencing showed no effects. Cardiac microvascular ECs showed a greater susceptibility to Gb3 loading as compared to macrovascular ECs.<h4>Conclusions</h4>Deregulation of key endothelial pathways as observed in FD vasculopathy is likely caused by intracellular Gb3 accumulation rather than deficiency of GLA. Human microvascular ECs, as opposed to macrovascular ECs, seem to be affected earlier and more severely by Gb3 accumulation and this notion may prove fundamental for future progresses in early diagnosis and management of FD patients.Mehdi NamdarCatherine GebhardRafael StudigerYi ShiPavani MocharlaChristian SchmiedPedro BrugadaThomas F LüscherGiovanni G CamiciPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 4, p e36373 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mehdi Namdar
Catherine Gebhard
Rafael Studiger
Yi Shi
Pavani Mocharla
Christian Schmied
Pedro Brugada
Thomas F Lüscher
Giovanni G Camici
Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
description <h4>Background</h4>Fabry disease (FD) is caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (GLA) resulting in the accumulation of globotriaosylsphingosine (Gb3) in a variety of tissues. While GLA deficiency was always considered as the fulcrum of the disease, recent attention shifted towards studying the mechanisms through which Gb3 accumulation in vascular cells leads to endothelial dysfunction and eventually multiorgan failure. In addition to the well-described macrovascular disease, FD is also characterized by abnormalities of microvascular function, which have been demonstrated by measurements of myocardial blood flow and coronary flow reserve. To date, the relative importance of Gb3 accumulation versus GLA deficiency in causing endothelial dysfunction is not fully understood; furthermore, its differential effects on cardiac micro- and macrovascular endothelial cells are not known.<h4>Methods and results</h4>In order to assess the effects of Gb3 accumulation versus GLA deficiency, human macro- and microvascular cardiac endothelial cells (ECs) were incubated with Gb3 or silenced by siRNA to GLA. Gb3 loading caused deregulation of several key endothelial pathways such as eNOS, iNOS, COX-1 and COX-2, while GLA silencing showed no effects. Cardiac microvascular ECs showed a greater susceptibility to Gb3 loading as compared to macrovascular ECs.<h4>Conclusions</h4>Deregulation of key endothelial pathways as observed in FD vasculopathy is likely caused by intracellular Gb3 accumulation rather than deficiency of GLA. Human microvascular ECs, as opposed to macrovascular ECs, seem to be affected earlier and more severely by Gb3 accumulation and this notion may prove fundamental for future progresses in early diagnosis and management of FD patients.
format article
author Mehdi Namdar
Catherine Gebhard
Rafael Studiger
Yi Shi
Pavani Mocharla
Christian Schmied
Pedro Brugada
Thomas F Lüscher
Giovanni G Camici
author_facet Mehdi Namdar
Catherine Gebhard
Rafael Studiger
Yi Shi
Pavani Mocharla
Christian Schmied
Pedro Brugada
Thomas F Lüscher
Giovanni G Camici
author_sort Mehdi Namdar
title Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
title_short Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
title_full Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
title_fullStr Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
title_full_unstemmed Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
title_sort globotriaosylsphingosine accumulation and not alpha-galactosidase-a deficiency causes endothelial dysfunction in fabry disease.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/22cdef7e000f48a58838623c6de322ef
work_keys_str_mv AT mehdinamdar globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT catherinegebhard globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT rafaelstudiger globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT yishi globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT pavanimocharla globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT christianschmied globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT pedrobrugada globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT thomasfluscher globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
AT giovannigcamici globotriaosylsphingosineaccumulationandnotalphagalactosidaseadeficiencycausesendothelialdysfunctioninfabrydisease
_version_ 1718423584050774016